APO Research
Talk to an analyst

APO RESEARCH · REPORT

Encephalitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Encephalitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchEncephalitis Vaccine Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Encephalitis Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Encephalitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Encephalitis Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Encephalitis Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Encephalitis Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Encephalitis Vaccine include Biken, Valneva, Tiantan Biological Products, Chengdu Institute of Biological Products, Lanzhou Institute of Biological Products, Liaoning Chengda, Sanofi Pasteur, Wuhan Institute of Biological Products and Yisheng Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Encephalitis Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Encephalitis Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Encephalitis Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Encephalitis Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Encephalitis Vaccine Segment by Company

Biken

Valneva

Tiantan Biological Products

Chengdu Institute of Biological Products

Lanzhou Institute of Biological Products

Liaoning Chengda

Sanofi Pasteur

Wuhan Institute of Biological Products

Yisheng Bio

Changchun Institute of Biological Products

Zhejiang Tianyuan Bio-Pharmaceutical

Encephalitis Vaccine Segment by Type

Inactivated Vaccine

Live Attenuated Vaccine

Encephalitis Vaccine Segment by Application

Child

Adult

Encephalitis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Encephalitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Encephalitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Encephalitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Encephalitis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Encephalitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Encephalitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Encephalitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Encephalitis Vaccine Industry Trends Table 2. Encephalitis Vaccine Industry Drivers Table 3. Encephalitis Vaccine Industry Opportunities and Challenges Table 4. Encephalitis Vaccine Industry Restraints Table 5. Global Encephalitis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Encephalitis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Encephalitis Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Encephalitis Vaccine Sales Market Share by Manufacturers Table 9. Global Encephalitis Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Encephalitis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Encephalitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Encephalitis Vaccine Manufacturers, Product Type & Application Table 13. Global Encephalitis Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Encephalitis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inactivated Vaccine Table 17. Major Manufacturers of Live Attenuated Vaccine Table 18. Global Encephalitis Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Encephalitis Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Encephalitis Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Encephalitis Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Encephalitis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Encephalitis Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Encephalitis Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Encephalitis Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Encephalitis Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Child Table 29. Major Manufacturers of Adult Table 30. Global Encephalitis Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 32. Global Encephalitis Vaccine Sales by Application (2027-2032) & (K Units) Table 33. Global Encephalitis Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Encephalitis Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Encephalitis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Encephalitis Vaccine Revenue by Application (2021-2026) & (K Units) Table 37. Global Encephalitis Vaccine Revenue by Application (2027-2032) & (K Units) Table 38. Global Encephalitis Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Encephalitis Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Encephalitis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Encephalitis Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Encephalitis Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Encephalitis Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Encephalitis Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Encephalitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 47. North America Encephalitis Vaccine Sales by Country (2027-2032) & (K Units) Table 48. Europe Encephalitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 50. Europe Encephalitis Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Encephalitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Encephalitis Vaccine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Encephalitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Encephalitis Vaccine Sales by Country (2027-2032) & (K Units) Table 57. Global Encephalitis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Encephalitis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Encephalitis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Encephalitis Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Encephalitis Vaccine Revenue Market Share by Region (2027-2032) Table 62. Biken Company Information Table 63. Biken Business Overview Table 64. Biken Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Biken Encephalitis Vaccine Product Portfolio Table 66. Biken Recent Development Table 67. Valneva Company Information Table 68. Valneva Business Overview Table 69. Valneva Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Valneva Encephalitis Vaccine Product Portfolio Table 71. Valneva Recent Development Table 72. Tiantan Biological Products Company Information Table 73. Tiantan Biological Products Business Overview Table 74. Tiantan Biological Products Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Tiantan Biological Products Encephalitis Vaccine Product Portfolio Table 76. Tiantan Biological Products Recent Development Table 77. Chengdu Institute of Biological Products Company Information Table 78. Chengdu Institute of Biological Products Business Overview Table 79. Chengdu Institute of Biological Products Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolio Table 81. Chengdu Institute of Biological Products Recent Development Table 82. Lanzhou Institute of Biological Products Company Information Table 83. Lanzhou Institute of Biological Products Business Overview Table 84. Lanzhou Institute of Biological Products Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolio Table 86. Lanzhou Institute of Biological Products Recent Development Table 87. Liaoning Chengda Company Information Table 88. Liaoning Chengda Business Overview Table 89. Liaoning Chengda Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Liaoning Chengda Encephalitis Vaccine Product Portfolio Table 91. Liaoning Chengda Recent Development Table 92. Sanofi Pasteur Company Information Table 93. Sanofi Pasteur Business Overview Table 94. Sanofi Pasteur Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Sanofi Pasteur Encephalitis Vaccine Product Portfolio Table 96. Sanofi Pasteur Recent Development Table 97. Wuhan Institute of Biological Products Company Information Table 98. Wuhan Institute of Biological Products Business Overview Table 99. Wuhan Institute of Biological Products Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolio Table 101. Wuhan Institute of Biological Products Recent Development Table 102. Yisheng Bio Company Information Table 103. Yisheng Bio Business Overview Table 104. Yisheng Bio Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Yisheng Bio Encephalitis Vaccine Product Portfolio Table 106. Yisheng Bio Recent Development Table 107. Changchun Institute of Biological Products Company Information Table 108. Changchun Institute of Biological Products Business Overview Table 109. Changchun Institute of Biological Products Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolio Table 111. Changchun Institute of Biological Products Recent Development Table 112. Zhejiang Tianyuan Bio-Pharmaceutical Company Information Table 113. Zhejiang Tianyuan Bio-Pharmaceutical Business Overview Table 114. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolio Table 116. Zhejiang Tianyuan Bio-Pharmaceutical Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Encephalitis Vaccine Distributors List Table 120. Encephalitis Vaccine Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Encephalitis Vaccine Product Image Figure 2. Global Encephalitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Encephalitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Encephalitis Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Encephalitis Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Encephalitis Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inactivated Vaccine Image Figure 9. Live Attenuated Vaccine Image Figure 10. Global Encephalitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Encephalitis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Encephalitis Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Encephalitis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Encephalitis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Encephalitis Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Child Image Figure 17. Adult Image Figure 18. Global Encephalitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Encephalitis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Encephalitis Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Encephalitis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Encephalitis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Encephalitis Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Encephalitis Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Encephalitis Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Encephalitis Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Encephalitis Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Encephalitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Encephalitis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Encephalitis Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Encephalitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Encephalitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Encephalitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Encephalitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Encephalitis Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Encephalitis Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Live Attenuated Vaccine
Applications
  • Child
  • Adult
Companies covered
  • Biken
  • Valneva
  • Tiantan Biological Products
  • Chengdu Institute of Biological Products
  • Lanzhou Institute of Biological Products
  • Liaoning Chengda
  • Sanofi Pasteur
  • Wuhan Institute of Biological Products
  • Yisheng Bio
  • Changchun Institute of Biological Products
  • Zhejiang Tianyuan Bio-Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Encephalitis Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Encephalitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Encephalitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Encephalitis Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Encephalitis Vaccine Market Dynamics
  1. 2.1 Encephalitis Vaccine Industry Trends
  2. 2.2 Encephalitis Vaccine Industry Drivers
  3. 2.3 Encephalitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Encephalitis Vaccine Industry Restraints
3 Encephalitis Vaccine Market by Manufacturers
  1. 3.1 Global Encephalitis Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Encephalitis Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Encephalitis Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Encephalitis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Encephalitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Encephalitis Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Encephalitis Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Encephalitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Encephalitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Encephalitis Vaccine Tier 1, Tier 2, and Tier 3
4 Encephalitis Vaccine Market by Type
  1. 4.1 Encephalitis Vaccine Type Introduction
  2. 4.1.1 Inactivated Vaccine
  3. 4.1.2 Live Attenuated Vaccine
  4. 4.2 Global Encephalitis Vaccine Sales by Type
  5. 4.2.1 Global Encephalitis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Encephalitis Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Encephalitis Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Encephalitis Vaccine Revenue by Type
  9. 4.3.1 Global Encephalitis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Encephalitis Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Encephalitis Vaccine Revenue Market Share by Type (2021-2032)
5 Encephalitis Vaccine Market by Application
  1. 5.1 Encephalitis Vaccine Application Introduction
  2. 5.1.1 Child
  3. 5.1.2 Adult
  4. 5.2 Global Encephalitis Vaccine Sales by Application
  5. 5.2.1 Global Encephalitis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Encephalitis Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Encephalitis Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Encephalitis Vaccine Revenue by Application
  9. 5.3.1 Global Encephalitis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Encephalitis Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Encephalitis Vaccine Revenue Market Share by Application (2021-2032)
6 Global Encephalitis Vaccine Sales by Region
  1. 6.1 Global Encephalitis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Encephalitis Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Encephalitis Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Encephalitis Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Encephalitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Encephalitis Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Encephalitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Encephalitis Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Encephalitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Encephalitis Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Encephalitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Encephalitis Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Encephalitis Vaccine Revenue by Region
  1. 7.1 Global Encephalitis Vaccine Revenue by Region
  2. 7.1.1 Global Encephalitis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Encephalitis Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Encephalitis Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Encephalitis Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Encephalitis Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Encephalitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Encephalitis Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Encephalitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Encephalitis Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Encephalitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Encephalitis Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Encephalitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Biken
  2. 8.1.1 Biken Company Information
  3. 8.1.2 Biken Business Overview
  4. 8.1.3 Biken Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biken Encephalitis Vaccine Product Portfolio
  6. 8.1.5 Biken Recent Developments
  7. 8.2 Valneva
  8. 8.2.1 Valneva Company Information
  9. 8.2.2 Valneva Business Overview
  10. 8.2.3 Valneva Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Valneva Encephalitis Vaccine Product Portfolio
  12. 8.2.5 Valneva Recent Developments
  13. 8.3 Tiantan Biological Products
  14. 8.3.1 Tiantan Biological Products Company Information
  15. 8.3.2 Tiantan Biological Products Business Overview
  16. 8.3.3 Tiantan Biological Products Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tiantan Biological Products Encephalitis Vaccine Product Portfolio
  18. 8.3.5 Tiantan Biological Products Recent Developments
  19. 8.4 Chengdu Institute of Biological Products
  20. 8.4.1 Chengdu Institute of Biological Products Company Information
  21. 8.4.2 Chengdu Institute of Biological Products Business Overview
  22. 8.4.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolio
  24. 8.4.5 Chengdu Institute of Biological Products Recent Developments
  25. 8.5 Lanzhou Institute of Biological Products
  26. 8.5.1 Lanzhou Institute of Biological Products Company Information
  27. 8.5.2 Lanzhou Institute of Biological Products Business Overview
  28. 8.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolio
  30. 8.5.5 Lanzhou Institute of Biological Products Recent Developments
  31. 8.6 Liaoning Chengda
  32. 8.6.1 Liaoning Chengda Company Information
  33. 8.6.2 Liaoning Chengda Business Overview
  34. 8.6.3 Liaoning Chengda Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Liaoning Chengda Encephalitis Vaccine Product Portfolio
  36. 8.6.5 Liaoning Chengda Recent Developments
  37. 8.7 Sanofi Pasteur
  38. 8.7.1 Sanofi Pasteur Company Information
  39. 8.7.2 Sanofi Pasteur Business Overview
  40. 8.7.3 Sanofi Pasteur Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Pasteur Encephalitis Vaccine Product Portfolio
  42. 8.7.5 Sanofi Pasteur Recent Developments
  43. 8.8 Wuhan Institute of Biological Products
  44. 8.8.1 Wuhan Institute of Biological Products Company Information
  45. 8.8.2 Wuhan Institute of Biological Products Business Overview
  46. 8.8.3 Wuhan Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolio
  48. 8.8.5 Wuhan Institute of Biological Products Recent Developments
  49. 8.9 Yisheng Bio
  50. 8.9.1 Yisheng Bio Company Information
  51. 8.9.2 Yisheng Bio Business Overview
  52. 8.9.3 Yisheng Bio Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Yisheng Bio Encephalitis Vaccine Product Portfolio
  54. 8.9.5 Yisheng Bio Recent Developments
  55. 8.10 Changchun Institute of Biological Products
  56. 8.10.1 Changchun Institute of Biological Products Company Information
  57. 8.10.2 Changchun Institute of Biological Products Business Overview
  58. 8.10.3 Changchun Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolio
  60. 8.10.5 Changchun Institute of Biological Products Recent Developments
  61. 8.11 Zhejiang Tianyuan Bio-Pharmaceutical
  62. 8.11.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information
  63. 8.11.2 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
  64. 8.11.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolio
  66. 8.11.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Encephalitis Vaccine Value Chain Analysis
  2. 9.1.1 Encephalitis Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Encephalitis Vaccine Production Mode & Process
  6. 9.2 Encephalitis Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Encephalitis Vaccine Distributors
  9. 9.2.3 Encephalitis Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst